There was no difference in liver stiffness measurements when comparing early-stage liver fibrosis (F0-F1) HCV patients to a younger/healthy non-HCV control unlike the FibroTest score primarily from elevated γ-glutamyl transferase and alpha-2-macroglobulin levels in circulation. This evidence concerns the gene A2M and Hepatic fibrosis.